An optimized approach to fluorescence in situ hybridization (FISH) testing
Comprehensive testing, simplified
Mayo Clinic Laboratories’ comprehensive fluorescence in situ hybridization (FISH) panels simplify the ordering process to ensure every patient receives the right test. Our diagnostic panels were designed to align with testing requirements of the National Comprehensive Cancer Network (NCCN) and the CLL-International Prognostic Index (CLL-IPI).
The inclusion of the most relevant genetic probes into our adult, pediatric, and monitoring FISH panels enables detailed insights on diagnosis, prognosis, and treatment options, equipping providers and patients with confidence that nothing related to the disease state was missed. Our streamlined panels save time and expense incurred through sequential test ordering by providing precision insights at the beginning of a patient’s medical journey, ensuring they are on the best path forward.
AMLAF | Adult AML FISH Panel
AMLPF | Pediatric FISH Panel
AMLMF | Specified FISH Panel
Learn more about how to order these evaluations at your institution.